{{Rsnum
|rsid=770189
|Gene=MEF2C
|Chromosome=5
|position=88792622
|Orientation=plus
|GMAF=0.4555
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=MEF2C
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 6.2 | 43.1 | 50.8
| HCB | 17.8 | 46.7 | 35.6
| JPT | 40.9 | 50.0 | 9.1
| YRI | 50.8 | 42.9 | 6.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 17.8 | 46.7 | 35.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs770189
|PubMedID=17903302
|Condition=Tonometry
|Gene=MEF2C
|Risk Allele=
|pValue=3.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs770189
|Name_s=
|Gene_s=MEF2C
|Feature=
|Evidence=PubMed ID:17903302; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness (Initial Sample Size: 644-1,327 individuals, depending on measure (Framingham; Replication Sample Size: NR). This variant is associated with Tonometry.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356427
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs770189
|overall_frequency_n=61
|overall_frequency_d=128
|overall_frequency=0.476562
|n_genomes=37
|n_genomes_annotated=0
|n_haplomes=53
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}